DWAYNE GRIFFIN: Open Payments
NPI 1699789727 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,728 in 206 payments from 24 companies in 2025. Trend: 2023 $4,022 · 2024 $4,112 · 2025 $4,728
Food & beverage: $4,359Education: $369
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $860 |
| GlaxoSmithKline, LLC. | 37 | $550 |
| Verona Pharma, Inc. | 30 | $521 |
| Inspire Medical Systems, Inc. | 5 | $347 |
| Insmed, Inc. | 16 | $341 |
| GENZYME CORPORATION | 11 | $326 |
| Actelion Pharmaceuticals US, Inc. | 5 | $247 |
| JAZZ PHARMACEUTICALS INC. | 5 | $205 |
| Amgen Inc. | 13 | $202 |
| Regeneron Healthcare Solutions, Inc. | 8 | $188 |
Products named: Ohtuvayre, DUPIXENT, TEZSPIRE, NUCALA, INSPIRE, Arikayce, FASENRA, OPSUMIT.
Industry payments across MI — which companies pay providers there.
